X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

RCKT

Closed

Rocket Pharmaceuticals Inc

2.59
+0.14 (+5.71%)
Last Update: 01 Jul 2025 23:25:00
Yesterday: 2.45
Day's Range: 2.4 - 2.715
Send
When Written:
 
16.77
Rocket Pharmaceuticals Inc is a clinical-stage biotechnology company that focuses on developing gene therapies for rare and devastating diseases. The company was founded in 2015 and is headquartered in New York City. Rocket Pharmaceuticals' pipeline includes gene therapies for several rare diseases, including Fanconi Anemia, Leukocyte Adhesion Deficiency-I, Pyruvate Kinase Deficiency, and Danon Disease. The company's lead product candidate, RP-L102, is a gene therapy for Fanconi Anemia, which is currently in Phase 1/2 clinical trials. Rocket Pharmaceuticals' mission is to bring hope to patients and families affected by rare diseases through the development of innovative gene therapies.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.11
X